References
- Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114–22
- McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1977; 55: 193–215
- Michet CJ, Jr, McKenna CH, Luthra HS, O'Fallen WM. Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74–8
- Schuknecht HF. Ear pathology in autoimmune disease. Adv Otorhinolaryngol 1991; 46: 50–70
- Seo T, Node M, Yukimasa A, Sakagami M. Furosemide loading vestibular evoked myogenic potential for unilateral Meniere's disease. Otol Neurotol 2003; 24: 283–8
- Mesa RA, Stensma DP, Pardanani A, Li C-Y, Elliot M, Kaufmann SH, et al. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood 2003; 101: 2534–41
- Yang CL, Brinckmann J, Vehring KH, Lehman H, Kekow J, Wolff HH, et al. Autoantibodies to cartilage in relapsing polychondritis. Arch Dermatol Res 1993; 285: 245–9
- Bergfeld WF. Relapsing polychondritis with positive direct immunofluorescence. Arch Dermatol Res 1978; 114: 127
- Cremer MA, Pitcock JA, Stuart JM, Kang AH, Townes AS. Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med 1981; 154: 535–40
- Hansson AS, Heinegard D, Holmdahl R. A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest 1999; 104: 589–98
- Lang B, Rothenfusser A, Lanchbury JS, Rauh G, Breedveld FC, Urlacher A, et al. Susceptibility to relapsing polychondritis associated with HLA-DR4. Arthritis Rheum 1993; 36: 660–4
- Diebold L, Rauh G, Jager K, Lohrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br J Haematol 1995; 89: 820–30
- Gordon BR, Coleman M, Kohen P, Day NK. Immunological abnormalities in myelofibrosis with activation of the complement system. Blood 1981; 58: 904–10
- Stahl RL, Hoppstein L, Davidson TG. Intraperitoneal chemotherapy with cytosine arabinoside in agnogenic myelofibrosis with myeloid metaplasia and ascites due to peritoneal extramedullary hematopoiesis. Am J Hematol 1993; 43: 156–7
- Cody DT, Sones DA. Relapsing polychondritis: audiovestibular manifestations. Laryngoscope 1971; 81: 1208–22
- Hoshino T, Kato I, Kodama A, Suzuki H. Sudden deafness in relapsing polychondritis. A scanning electron microscopy study. Acta Otolaryngol 1978; 86: 418–27
- Kimura Y, Miwa H, Furukawa M, Mizukami Y. Relapsing polychondritis presented as inner ear involvement. J Laryngol Otol 1996; 110: 154–7
- Kobori T, Masuda H, Okada K, Kurihara S, Amano Y, Tajima S, et al. Relapsing polychondritis: etiology of audiovestibular disorders. Nippon Jibiinkoka Gakkai Kaiho 1987; 90: 1181–7
- Yoo TJ, Yazawa Y, Tomoda K, Floid R. Type II collagen induced autoimmune endolymphatic hydrops in guinea pig. Science 1983; 222: 65–7
- Yoo TJ. Etiopathogenesis of Meniere's disease: a hypothesis. Ann Otol Rhinol Laryngol 1984; 113: 6–12
- Yoo TJ, Shea J, Jr, Ge X, Kwon SS, Yazawa Y, Sener O, et al. Presence of autoantibodies in the sera of Meniere's disease. Ann Otol Rhinol Laryngol 2001; 110: 425–9
- Brooks GB. Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck Surg 1986; 112: 536–40